-+ 0.00%
-+ 0.00%
-+ 0.00%

West Pharmaceutical Servs Raises FY2025 Adj EPS Guidance from $6.00-$6.20 to $6.15-$6.35 vs $6.14 Est; Raises FY2025 Sales Guidance from $2.88B-$2.90B to $2.94B-$2.98B vs $2.90B Est

Benzinga·04/24/2025 10:09:00
Listen to the news
West Pharmaceutical Servs (NYSE:WST) raises FY2025 Adj EPS guidance from $6.00-$6.20 to $6.15-$6.35 vs $6.14 analyst estimate. Raises FY2025 sales outlook from $2.88 billion-$2.90 billion to $2.94 billion-$2.98 billion vs $2.90 billion estimate.